Lobetyolin reshapes gut microbiota and bile acid metabolism to improve androgen-driven PCOS phenotypes in mice
Lijuan Li, Pingping Lin, Siyuan Liu, Yuning Zhang, Siqi Wang, Jingtao Liang, Ruyu Wang, Guofeng Duan, Aixiang Chen · 2026
Read Lobetyolin reshapes gut microbiota and bile acid metabolism to improve androgen-driven PCOS phenotypes in mice by Lijuan Li, Pingping Lin, Siyuan Liu, Yuning Zhang, Siqi Wang, Jingtao Liang, Ruyu Wang, Guofeng Duan, Aixiang Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13176234.txt.
Description
Nine researchers test a plant compound, lobetyolin, against polycystic ovary syndrome in mice. The syndrome mixes excess male hormones, insulin trouble, steady inflammation, and womb lining harm. Mice given a hormone that mimics the condition received the compound for twenty-eight days. The team tracked cycles, hormones, sugar control, gut microbes, and bile acids.
Treatment restored regular cycles, lowered the hormone ratio and testosterone, and improved insulin sensitivity. It turned down two androgen-making enzymes in the ovary while turning up a third that clears androgens. Gut diversity rose, helpful bacterial groups grew, and bile acid levels tied to better metabolism increased. In the womb, the compound calmed blood vessel overgrowth signals and restored protective ones. The authors read the gut-to-bile-acid route as the hub of the benefit and propose the compound for deeper study.
Catalog record
| CREATOR | Lijuan Li, Pingping Lin, Siyuan Liu, Yuning Zhang, Siqi Wang, Jingtao Liang, Ruyu Wang, Guofeng Duan, Aixiang Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |